Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful

doi:10.5500/wjt.v5.i4.338

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6738)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

466

WORD

277

HTML

2824

Figures (1-6)

195

Tables (1-4)

127

Sum=3889

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

865

Download

1984

Sum=2849

Dec 24, 2015 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Transplant. Dec 24, 2015; 5(4): 338-347
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.338

Full Size Figure Download Figure

Figure 4 Cyclosporine daily dose (A), cyclosporine blood concentrations (B) and everolimus daily dose (C) during the first two years of follow-up. MMF: Mycophenolate mofetyl.

Citation: González F, Valjalo R. Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful. World J Transplant 2015; 5(4): 338-347
URL: https://www.wjgnet.com/2220-3230/full/v5/i4/338.htm
DOI: https://dx.doi.org/10.5500/wjt.v5.i4.338